BUPIVACAINE HYDROCHLORIDE

BUPIVACAINE HYDROCHLORIDE was reported 7821 times

BUPIVACAINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHONDROLYSIS 141 0.3000
1 ANTERIOR SPINAL ARTERY SYNDROME 16 0.1905
2 ANAESTHETIC COMPLICATION 325 0.1209
3 POST PROCEDURAL HYPOTENSION 10 0.1176
4 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 92 0.0866
5 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 6 0.0800
6 MATERNAL EXPOSURE DURING DELIVERY 75 0.0757
7 VENTILATION PERFUSION MISMATCH 21 0.0747
8 OVERLAP SYNDROME 46 0.0657
9 ANAESTHETIC COMPLICATION CARDIAC 4 0.0580
10 CAUDA EQUINA SYNDROME 44 0.0573
11 PRIMARY STABBING HEADACHE 4 0.0563
12 SPINAL ANAESTHESIA 4 0.0519
13 CHONDROMALACIA 13 0.0456
14 NEUROMUSCULAR BLOCKADE 10 0.0446
15 FOETAL EXPOSURE DURING DELIVERY 28 0.0413
16 SODIUM RETENTION 8 0.0392
17 BRACHIAL PLEXOPATHY 8 0.0362
18 RENIN INCREASED 8 0.0293
19 OCULAR RETROBULBAR HAEMORRHAGE 4 0.0288
20 JAW CLICKING 6 0.0282
21 RHYTHM IDIOVENTRICULAR 8 0.0246
22 ARACHNOIDITIS 17 0.0246
23 URINARY RETENTION POSTOPERATIVE 4 0.0242
24 MENINGITIS CHEMICAL 5 0.0227
25 CATHETER SITE RELATED REACTION 16 0.0213
26 SPINAL CORD INFARCTION 9 0.0204
27 DRUG EFFECT PROLONGED 11 0.0199
28 HYPOCHOLESTEROLAEMIA 7 0.0198
29 NEUROMUSCULAR BLOCK PROLONGED 7 0.0190
30 PHRENIC NERVE PARALYSIS 4 0.0183
31 DELAYED RECOVERY FROM ANAESTHESIA 17 0.0179
32 SYSTEMIC MASTOCYTOSIS 5 0.0166
33 LUPUS VULGARIS 20 0.0159
34 NERVE BLOCK 9 0.0154
35 PROCEDURAL HYPOTENSION 13 0.0153
36 PRODUCT APPEARANCE CONFUSION 14 0.0152
37 MYOFASCIAL PAIN SYNDROME 10 0.0141
38 DEVICE COMPUTER ISSUE 4 0.0134
39 CORNEAL REFLEX DECREASED 5 0.0133
40 BRADYCARDIA FOETAL 11 0.0132
41 DEEP VEIN THROMBOSIS POSTOPERATIVE 26 0.0130
42 PRE-EXISTING DISEASE 6 0.0123
43 INTRACRANIAL HYPOTENSION 8 0.0123
44 OPERATIVE HAEMORRHAGE 5 0.0112
45 THERAPEUTIC PRODUCT EFFECT PROLONGED 5 0.0110
46 ANAESTHESIA 4 0.0110
47 PRODUCT MEASURED POTENCY ISSUE 11 0.0109
48 SUSPECTED PRODUCT CONTAMINATION 11 0.0109
49 SPINAL CORD OEDEMA 4 0.0108
50 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 6 0.0107
51 DRUG EFFECT DELAYED 48 0.0106
52 POST LUMBAR PUNCTURE SYNDROME 11 0.0106
53 RETINITIS 18 0.0104
54 WOUND NECROSIS 5 0.0104
55 ARACHNOID CYST 4 0.0102
56 TOXIC ANTERIOR SEGMENT SYNDROME 11 0.0101
57 SENSORIMOTOR DISORDER 5 0.0101
58 MYOPATHY TOXIC 6 0.0097
59 PARAPLEGIA 28 0.0097
60 MEDICAL DEVICE SITE INFECTION 6 0.0097
61 JOINT INJURY 204 0.0095
62 JOINT RANGE OF MOTION DECREASED 127 0.0095
63 UPPER AIRWAY OBSTRUCTION 8 0.0090
64 ACUTE STRESS DISORDER 3 0.0090
65 PRODUCT CLOSURE ISSUE 5 0.0090
66 OCCIPITAL NEURALGIA 5 0.0088
67 HELICOBACTER INFECTION 91 0.0088
68 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 10 0.0080
69 BRONCHOPLEURAL FISTULA 3 0.0080
70 BREATH HOLDING 3 0.0078
71 APGAR SCORE LOW 10 0.0078
72 ANAESTHETIC COMPLICATION NEUROLOGICAL 7 0.0077
73 ARTHRITIS INFECTIVE 35 0.0075
74 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 5 0.0075
75 KOUNIS SYNDROME 17 0.0075
76 PROCEDURAL NAUSEA 6 0.0075
77 MATERNAL EXPOSURE TIMING UNSPECIFIED 28 0.0074
78 FACET JOINT SYNDROME 24 0.0074
79 SURGICAL PROCEDURE REPEATED 5 0.0073
80 HYPERCHOLESTEROLAEMIA 69 0.0071
81 FOETAL HEART RATE DECELERATION ABNORMALITY 5 0.0071
82 ARTHRITIS BACTERIAL 29 0.0071
83 PRODUCT PACKAGING CONFUSION 17 0.0070
84 SPINAL EPIDURAL HAEMATOMA 4 0.0068
85 ALLERGY TEST POSITIVE 3 0.0066
86 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 43 0.0066
87 DISLOCATION OF VERTEBRA 15 0.0066
88 THERAPEUTIC PRODUCT EFFECT DELAYED 30 0.0066
89 NECROTISING FASCIITIS 23 0.0065
90 LIVE BIRTH 53 0.0063
91 SERONEGATIVE ARTHRITIS 7 0.0061
92 NORMAL NEWBORN 33 0.0061
93 EXTRADURAL HAEMATOMA 8 0.0060
94 CARDIOTOXICITY 53 0.0059
95 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 4 0.0059
96 SPINAL CORD INJURY 10 0.0057
97 MENINGITIS BACTERIAL 8 0.0056
98 PORPHYRIA ACUTE 8 0.0056
99 DIPLEGIA 11 0.0056
100 SOMATIC SYMPTOM DISORDER 6 0.0056
101 SEROMA 7 0.0055
102 BLOOD PH INCREASED 3 0.0054
103 SKIN TEST POSITIVE 5 0.0054
104 BONE CYST 5 0.0053
105 STAPHYLOCOCCUS TEST POSITIVE 11 0.0052
106 POSTPARTUM HAEMORRHAGE 7 0.0052
107 MUSCULOSKELETAL PAIN 270 0.0051
108 ALLODYNIA 6 0.0051
109 SINUS ARREST 8 0.0051
110 STRIDOR 15 0.0051
111 IMPLANT SITE EXTRAVASATION 4 0.0051
112 DEVICE DAMAGE 4 0.0050
113 ELECTROMECHANICAL DISSOCIATION 4 0.0050
114 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 11 0.0050
115 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44 0.0050
116 HYPOGLYCAEMIA NEONATAL 8 0.0049
117 MUSCULOSKELETAL DISCOMFORT 85 0.0049
118 EXOSTOSIS 45 0.0049
119 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 83 0.0048
120 GAZE PALSY 8 0.0047
121 FOLLICULITIS 49 0.0047
122 IATROGENIC INJURY 6 0.0047
123 BLOOD PRESSURE IMMEASURABLE 7 0.0046
124 AREFLEXIA 12 0.0045
125 ACTIVITIES OF DAILY LIVING IMPAIRED 88 0.0044
126 CATHETER RELATED COMPLICATION 5 0.0044
127 RETINAL ARTERY OCCLUSION 11 0.0043
128 PO2 DECREASED 5 0.0043
129 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 9 0.0043
130 C-REACTIVE PROTEIN 4 0.0043
131 BONE EROSION 15 0.0042
132 QUADRIPARESIS 7 0.0042
133 CERVICAL RADICULOPATHY 3 0.0042
134 EXOPHTHALMOS 9 0.0042
135 PYELOCALIECTASIS 4 0.0042
136 SWOLLEN JOINT COUNT INCREASED 13 0.0041
137 INJECTION SITE ABSCESS 10 0.0040
138 CORNEAL OEDEMA 9 0.0040
139 BRAIN STEM SYNDROME 3 0.0040
140 MUSCULOSKELETAL DISORDER 75 0.0039
141 PARAPARESIS 7 0.0039
142 VOCAL CORD PARALYSIS 7 0.0039
143 CONJUNCTIVAL OEDEMA 4 0.0039
144 NEURITIS 6 0.0039
145 APNOEA 30 0.0038
146 MUSCLE INJURY 31 0.0037
147 CARTILAGE INJURY 9 0.0036
148 FIBROMYALGIA 88 0.0036
149 PRODUCT LABEL CONFUSION 21 0.0036
150 TONIC CONVULSION 5 0.0035
151 PROCEDURAL COMPLICATION 27 0.0035
152 ANORECTAL DISORDER 7 0.0035
153 BLOOD PH DECREASED 6 0.0035
154 RESPIRATORY DEPRESSION 43 0.0035
155 CARBON DIOXIDE DECREASED 4 0.0035
156 LUMBAR RADICULOPATHY 4 0.0035
157 FOOT DEFORMITY 38 0.0034
158 AXIAL SPONDYLOARTHRITIS 3 0.0034
159 RADICULOPATHY 9 0.0034
160 INCISION SITE PAIN 4 0.0034
161 STRABISMUS 10 0.0034
162 COMPLEX REGIONAL PAIN SYNDROME 5 0.0034
163 RHEUMATIC FEVER 15 0.0034
164 PULSE ABSENT 16 0.0034
165 HYPERTHERMIA MALIGNANT 5 0.0034
166 X-RAY ABNORMAL 6 0.0034
167 INFUSION SITE REACTION 10 0.0033
168 CHONDROPATHY 9 0.0033
169 GRIP STRENGTH DECREASED 29 0.0033
170 INTELLECTUAL DISABILITY 5 0.0033
171 SUSPECTED PRODUCT QUALITY ISSUE 6 0.0033
172 POOR QUALITY DRUG ADMINISTERED 21 0.0032
173 MONOPLEGIA 14 0.0032
174 DRUG EFFECT INCOMPLETE 117 0.0032
175 NEUROTOXICITY 56 0.0032
176 HYPERPARATHYROIDISM SECONDARY 8 0.0032
177 PERIPHERAL VENOUS DISEASE 13 0.0032
178 CAESAREAN SECTION 37 0.0032
179 BRAIN STEM HAEMORRHAGE 3 0.0032
180 OPHTHALMOPLEGIA 5 0.0032
181 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
182 MYELOPATHY 6 0.0032
183 NEONATAL DISORDER 5 0.0032
184 PARALYSIS 45 0.0031
185 MYOCLONUS 37 0.0031
186 DUODENAL ULCER PERFORATION 23 0.0031
187 PERIARTHRITIS 7 0.0031
188 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 22 0.0031
189 JOINT CREPITATION 6 0.0030
190 METHAEMOGLOBINAEMIA 7 0.0030
191 BONE MARROW OEDEMA 3 0.0029
192 HAND DEFORMITY 38 0.0029
193 PUPIL FIXED 5 0.0029
194 MENISCUS LESION 4 0.0029
195 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
196 RESPIRATORY RATE DECREASED 9 0.0029
197 ONYCHOMADESIS 12 0.0029
198 SENSORY LOSS 23 0.0029
199 MYELITIS TRANSVERSE 4 0.0028
200 JAUNDICE CHOLESTATIC 10 0.0028
201 CATAPLEXY 4 0.0028
202 INADEQUATE ANALGESIA 24 0.0028
203 DEVICE INFUSION ISSUE 7 0.0028
204 MATERNAL EXPOSURE DURING PREGNANCY 246 0.0028
205 ANGLE CLOSURE GLAUCOMA 7 0.0027
206 INJECTION SITE INFECTION 9 0.0027
207 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
208 BLEPHAROSPASM 17 0.0027
209 SKIN NECROSIS 14 0.0027
210 SCIATICA 43 0.0027
211 WRONG PRODUCT ADMINISTERED 18 0.0027
212 HYPERCAPNIA 8 0.0027
213 OSTEOARTHRITIS 112 0.0026
214 ANGIONEUROTIC OEDEMA 7 0.0026
215 GRANULOMA 9 0.0026
216 RHEUMATOID FACTOR POSITIVE 15 0.0026
217 MYELITIS 4 0.0026
218 BURSITIS 31 0.0026
219 MENINGITIS 17 0.0025
220 CYSTITIS INTERSTITIAL 4 0.0025
221 BREAST CANCER STAGE III 16 0.0025
222 SUSPECTED OFF LABEL USE 11 0.0024
223 HYPERAESTHESIA 20 0.0024
224 DEAFNESS NEUROSENSORY 8 0.0024
225 BRADYCARDIA NEONATAL 3 0.0024
226 NEPHROGENIC ANAEMIA 11 0.0024
227 FOETAL DISTRESS SYNDROME 5 0.0024
228 WRONG DRUG ADMINISTERED 21 0.0024
229 ROTATOR CUFF SYNDROME 30 0.0023
230 BLOOD CHLORIDE INCREASED 4 0.0023
231 SPINAL CORD COMPRESSION 9 0.0023
232 COMPARTMENT SYNDROME 6 0.0023
233 NO THERAPEUTIC RESPONSE 28 0.0023
234 RESPIRATORY ACIDOSIS 9 0.0023
235 BRADYCARDIA 121 0.0023
236 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
237 FAECES PALE 5 0.0022
238 PARESIS 5 0.0022
239 ANION GAP INCREASED 3 0.0022
240 ARTERIOSPASM CORONARY 9 0.0022
241 WEIGHT BEARING DIFFICULTY 6 0.0022
242 CORNEAL OPACITY 3 0.0022
243 PREMATURE DELIVERY 35 0.0022
244 CLONUS 6 0.0022
245 HEPATIC CIRRHOSIS 41 0.0022
246 VITREOUS HAEMORRHAGE 6 0.0022
247 TYPE 2 DIABETES MELLITUS 73 0.0022
248 CEREBROSPINAL FLUID LEAKAGE 4 0.0022
249 MEDICAL DEVICE COMPLICATION 16 0.0022
250 IMPLANT SITE INFECTION 5 0.0021
251 POST PROCEDURAL COMPLICATION 41 0.0021
252 HYPOXIA 75 0.0021
253 INTERVERTEBRAL DISCITIS 4 0.0021
254 JAUNDICE NEONATAL 4 0.0021
255 LIP DRY 19 0.0021
256 WOUND DEHISCENCE 7 0.0021
257 MOTOR DYSFUNCTION 21 0.0021
258 ATROPHY 4 0.0021
259 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
260 AUTOIMMUNE DISORDER 20 0.0020
261 PRESCRIBED OVERDOSE 39 0.0020
262 DRUG INEFFECTIVE 2645 0.0020
263 TACHYARRHYTHMIA 5 0.0020
264 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
265 FOAMING AT MOUTH 4 0.0020
266 VENTRICULAR FIBRILLATION 22 0.0020
267 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
268 UNRESPONSIVE TO STIMULI 51 0.0020
269 QUADRIPLEGIA 4 0.0019
270 GLOSSODYNIA 43 0.0019
271 WOUND INFECTION 21 0.0019
272 MYOSITIS 17 0.0019
273 LOWER LIMB FRACTURE 36 0.0019
274 VENTRICULAR HYPOKINESIA 6 0.0019
275 COLON CANCER METASTATIC 3 0.0019
276 MATERNAL DRUGS AFFECTING FOETUS 14 0.0018
277 BRADYARRHYTHMIA 3 0.0018
278 PRODUCT FORMULATION ISSUE 12 0.0018
279 VENTRICULAR TACHYCARDIA 30 0.0018
280 INJECTION SITE INFLAMMATION 9 0.0018
281 C-REACTIVE PROTEIN INCREASED 65 0.0018
282 ANAPHYLACTIC SHOCK 46 0.0018
283 FEAR OF DEATH 4 0.0018
284 HYPOAESTHESIA 265 0.0018
285 PERONEAL NERVE PALSY 10 0.0018
286 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
287 PUSTULAR PSORIASIS 6 0.0017
288 SENSORY DISTURBANCE 28 0.0017
289 CARDIAC ARREST 144 0.0017
290 DIFFICULTY IN WALKING 6 0.0017
291 GRAND MAL CONVULSION 16 0.0017
292 SYNOVIAL CYST 8 0.0017
293 BREAKTHROUGH PAIN 4 0.0017
294 JOINT DISLOCATION 18 0.0017
295 TACHYPNOEA 23 0.0017
296 HYPOTHERMIA 17 0.0017
297 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
298 BUNDLE BRANCH BLOCK LEFT 7 0.0016
299 SPONDYLITIS 6 0.0016
300 CIRCULATORY COLLAPSE 28 0.0016
301 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
302 UTERINE HAEMORRHAGE 7 0.0016
303 MUSCLE SPASTICITY 20 0.0016
304 FIBROSIS 5 0.0016
305 PRODUCT LABEL ISSUE 11 0.0016
306 NERVE INJURY 18 0.0016
307 DRUG TOXICITY 22 0.0016
308 IMPAIRED HEALING 53 0.0016
309 SUFFOCATION FEELING 4 0.0016
310 SYNOVITIS 29 0.0016
311 INCORRECT PRODUCT STORAGE 21 0.0016
312 HAEMODYNAMIC INSTABILITY 12 0.0016
313 SEDATION COMPLICATION 4 0.0016
314 EUPHORIC MOOD 16 0.0016
315 C-REACTIVE PROTEIN ABNORMAL 10 0.0016
316 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
317 SINUS TACHYCARDIA 22 0.0015
318 PERICARDITIS 26 0.0015
319 STAPHYLOCOCCAL INFECTION 51 0.0015
320 DRUG EXPOSURE DURING PREGNANCY 52 0.0015
321 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
322 BLOOD CHOLESTEROL INCREASED 71 0.0015
323 DRUG EFFECT DECREASED 82 0.0015
324 PEMPHIGUS 19 0.0015
325 STATUS EPILEPTICUS 17 0.0015
326 PROSTATE CANCER METASTATIC 5 0.0015
327 ANXIETY DISORDER 5 0.0015
328 DRUG-INDUCED LIVER INJURY 46 0.0015
329 ANAPHYLACTIC REACTION 81 0.0015
330 ATELECTASIS 14 0.0014
331 STREPTOCOCCAL INFECTION 8 0.0014
332 ROAD TRAFFIC ACCIDENT 60 0.0014
333 GAIT INABILITY 47 0.0014
334 PURULENT DISCHARGE 6 0.0014
335 INCORRECT ROUTE OF DRUG ADMINISTRATION 50 0.0014
336 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
337 BONE LESION 5 0.0014
338 HYPOTENSION 278 0.0014
339 BACK INJURY 15 0.0014
340 URINE OUTPUT DECREASED 12 0.0014
341 CORNEAL DISORDER 3 0.0014
342 EXPOSURE DURING PREGNANCY 85 0.0014
343 ARTHROPATHY 76 0.0014
344 WALKING AID USER 9 0.0014
345 RED BLOOD CELL SEDIMENTATION RATE INCREASED 15 0.0014
346 IRRITABLE BOWEL SYNDROME 29 0.0014
347 HEPATIC ENZYME INCREASED 92 0.0013
348 CHOLECYSTITIS CHRONIC 9 0.0013
349 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
350 RESPIRATORY ARREST 37 0.0013
351 MOVEMENT DISORDER 43 0.0013
352 LUPUS-LIKE SYNDROME 12 0.0013
353 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
354 PRESCRIBED UNDERDOSE 26 0.0013
355 PREMATURE BABY 39 0.0013
356 BRAIN DEATH 4 0.0013
357 PANIC DISORDER 5 0.0013
358 URINARY INCONTINENCE 38 0.0013
359 EPILEPSY 39 0.0013
360 SPINAL COLUMN STENOSIS 6 0.0013
361 DELIRIUM 44 0.0013
362 BLADDER PAIN 4 0.0013
363 MIOSIS 10 0.0012
364 DISCOMFORT 76 0.0012
365 SINUS BRADYCARDIA 12 0.0012
366 SPINAL FUSION SURGERY 5 0.0012
367 NEUROLOGICAL SYMPTOM 7 0.0012
368 URINARY RETENTION 40 0.0012
369 AORTIC ARTERIOSCLEROSIS 3 0.0012
370 WOUND COMPLICATION 4 0.0012
371 ATRIOVENTRICULAR BLOCK 9 0.0012
372 BLOOD CHLORIDE DECREASED 3 0.0012
373 RESPIRATORY DISTRESS 32 0.0012
374 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
375 HYPOPNOEA 4 0.0012
376 ONYCHOMYCOSIS 5 0.0011
377 SPINAL OSTEOARTHRITIS 10 0.0011
378 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
379 LIGAMENT RUPTURE 5 0.0011
380 PHYSICAL DISABILITY 5 0.0011
381 BLOOD PRESSURE DECREASED 75 0.0011
382 ABSCESS 18 0.0011
383 PRODUCT CONTAMINATION 4 0.0011
384 IMPLANT SITE PAIN 5 0.0011
385 BLOOD SODIUM INCREASED 3 0.0011
386 ANAL INCONTINENCE 10 0.0011
387 HYPOTONIA 11 0.0011
388 SWELLING 103 0.0011
389 BLOOD PHOSPHORUS DECREASED 4 0.0011
390 TENDON DISORDER 7 0.0011
391 NEURALGIA 26 0.0011
392 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
393 POST-TRAUMATIC STRESS DISORDER 7 0.0010
394 PULMONARY FIBROSIS 20 0.0010
395 INJURY 73 0.0010
396 ULCER HAEMORRHAGE 7 0.0010
397 RASH VESICULAR 5 0.0010
398 STRESS CARDIOMYOPATHY 6 0.0010
399 NAIL DISORDER 9 0.0010
400 WOUND SECRETION 4 0.0010
401 ECCHYMOSIS 7 0.0010
402 MOBILITY DECREASED 73 0.0010
403 OXYGEN SATURATION DECREASED 57 0.0010
404 INFUSION RELATED REACTION 67 0.0010
405 DIABETIC NEUROPATHY 5 0.0010
406 CREPITATIONS 3 0.0010
407 HYPOAESTHESIA ORAL 15 0.0010
408 CRANIOCEREBRAL INJURY 3 0.0010
409 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
410 PERIPHERAL ISCHAEMIA 4 0.0010
411 CONVULSION 56 0.0010
412 BLOOD CALCIUM DECREASED 11 0.0010
413 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
414 VENTRICULAR EXTRASYSTOLES 10 0.0010
415 LACERATION 9 0.0010
416 CYANOSIS 15 0.0010
417 JOINT STIFFNESS 25 0.0010
418 MULTIPLE INJURIES 6 0.0010
419 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67 0.0009
420 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
421 FACIAL PARALYSIS 8 0.0009
422 THERAPEUTIC PRODUCT EFFECT DECREASED 42 0.0009
423 MENTAL STATUS CHANGES 26 0.0009
424 MYDRIASIS 12 0.0009
425 SCAR 16 0.0009
426 PHARMACEUTICAL PRODUCT COMPLAINT 24 0.0009
427 COELIAC DISEASE 9 0.0009
428 SEDATION 24 0.0009
429 RHINITIS ALLERGIC 4 0.0009
430 LOSS OF CONSCIOUSNESS 115 0.0009
431 POSTOPERATIVE WOUND INFECTION 6 0.0009
432 EYELID PTOSIS 9 0.0009
433 END STAGE RENAL DISEASE 16 0.0009
434 OSTEOPOROSIS 36 0.0009
435 HYPERTONIA 5 0.0009
436 ISCHAEMIA 4 0.0009
437 JOINT EFFUSION 6 0.0009
438 METASTASES TO LUNG 10 0.0009
439 GENERAL PHYSICAL HEALTH DETERIORATION 100 0.0009
440 EAR INFECTION 23 0.0009
441 MUSCLE TIGHTNESS 14 0.0009
442 HYPERTRANSAMINASAEMIA 6 0.0009
443 COMA 41 0.0009
444 WOUND 24 0.0009
445 STOMATITIS 52 0.0009
446 PERFORMANCE STATUS DECREASED 4 0.0009
447 HIP ARTHROPLASTY 13 0.0008
448 PRE-ECLAMPSIA 4 0.0008
449 PRODUCT ADMINISTRATION ERROR 17 0.0008
450 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
451 FAECAL INCONTINENCE 4 0.0008
452 SKIN LACERATION 9 0.0008
453 FINGER DEFORMITY 4 0.0008
454 OBESITY 13 0.0008
455 LIVER INJURY 20 0.0008
456 PSORIATIC ARTHROPATHY 33 0.0008
457 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
458 PRODUCT QUALITY ISSUE 109 0.0008
459 NERVOUS SYSTEM DISORDER 25 0.0008
460 BRAIN INJURY 8 0.0008
461 MITRAL VALVE INCOMPETENCE 9 0.0008
462 CELLULITIS 40 0.0008
463 AUTOIMMUNE THYROIDITIS 3 0.0008
464 ECONOMIC PROBLEM 12 0.0008
465 DRUG TOLERANCE 4 0.0008
466 RESPIRATORY RATE INCREASED 7 0.0008
467 DEVICE FAILURE 12 0.0008
468 SLEEP APNOEA SYNDROME 15 0.0008
469 BOWEL MOVEMENT IRREGULARITY 6 0.0008
470 HEPATITIS ACUTE 5 0.0008
471 CARDIOGENIC SHOCK 11 0.0008
472 TACHYCARDIA 68 0.0008
473 TRANSFUSION 8 0.0008
474 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
475 PNEUMOTHORAX 12 0.0008
476 TRICUSPID VALVE INCOMPETENCE 6 0.0008
477 INJECTION SITE DISCHARGE 4 0.0007
478 HYPERTENSION 157 0.0007
479 MUSCULAR WEAKNESS 84 0.0007
480 MEDICATION ERROR 41 0.0007
481 ANAPHYLACTOID REACTION 3 0.0007
482 PROCEDURAL PAIN 20 0.0007
483 INFLAMMATION 37 0.0007
484 MASS 10 0.0007
485 ANGIOPATHY 4 0.0007
486 RENAL TUBULAR NECROSIS 7 0.0007
487 DISABILITY 14 0.0007
488 ABSCESS LIMB 3 0.0007
489 BRONCHOSPASM 10 0.0007
490 TINNITUS 32 0.0007
491 DRUG WITHDRAWAL SYNDROME 61 0.0007
492 DIPLOPIA 18 0.0007
493 HYPERVENTILATION 4 0.0007
494 HYPOKINESIA 10 0.0007
495 EYELID OEDEMA 8 0.0007
496 HYPERTRIGLYCERIDAEMIA 4 0.0007
497 RESTLESSNESS 25 0.0007
498 LUNG INFILTRATION 6 0.0007
499 DRUG INTOLERANCE 65 0.0007
500 THERAPY NON-RESPONDER 30 0.0007
501 ENDOPHTHALMITIS 4 0.0007
502 RENAL FAILURE CHRONIC 5 0.0006
503 PHARYNGEAL OEDEMA 10 0.0006
504 DEVICE RELATED INFECTION 10 0.0006
505 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
506 BLISTER 36 0.0006
507 ADVERSE EVENT 59 0.0006
508 ADVERSE DRUG REACTION 57 0.0006
509 DENTAL CARIES 7 0.0006
510 DRUG SCREEN POSITIVE 5 0.0006
511 SUBDURAL HAEMATOMA 9 0.0006
512 HEPATITIS 16 0.0006
513 COLD SWEAT 11 0.0006
514 PROCTALGIA 4 0.0006
515 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
516 PRESYNCOPE 15 0.0006
517 DEEP VEIN THROMBOSIS 40 0.0006
518 OSTEOMYELITIS 11 0.0006
519 INTENTIONAL PRODUCT USE ISSUE 53 0.0006
520 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
521 BREAST CANCER STAGE II 5 0.0006
522 CARDIAC FAILURE ACUTE 4 0.0006
523 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
524 HEART RATE DECREASED 21 0.0006
525 CORONARY ARTERY STENOSIS 3 0.0006
526 APHASIA 18 0.0006
527 METASTASES TO LYMPH NODES 4 0.0006
528 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
529 OEDEMA 32 0.0006
530 NIGHT SWEATS 19 0.0006
531 MUSCLE RIGIDITY 7 0.0006
532 EYE MOVEMENT DISORDER 4 0.0006
533 CEREBRAL ISCHAEMIA 3 0.0006
534 DYSSTASIA 17 0.0006
535 CHOLESTASIS 11 0.0006
536 CARPAL TUNNEL SYNDROME 8 0.0006
537 BLOOD LACTIC ACID INCREASED 3 0.0006
538 CARDIOMEGALY 7 0.0006
539 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
540 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
541 SHOCK 13 0.0006
542 HYPERSENSITIVITY 104 0.0006
543 BREAST CANCER METASTATIC 6 0.0006
544 IMPAIRED QUALITY OF LIFE 8 0.0006
545 BEHAVIOUR DISORDER 3 0.0006
546 BRAIN OEDEMA 7 0.0006
547 BACK DISORDER 9 0.0006
548 CONDITION AGGRAVATED 168 0.0006
549 CARDIO-RESPIRATORY ARREST 23 0.0005
550 PARAESTHESIA 86 0.0005
551 ORAL DISORDER 4 0.0005
552 BLINDNESS TRANSIENT 4 0.0005
553 BLINDNESS 22 0.0005
554 NECK PAIN 30 0.0005
555 PAIN 329 0.0005
556 ACUTE PULMONARY OEDEMA 3 0.0005
557 INFECTION 77 0.0005
558 SEIZURE 61 0.0005
559 WITHDRAWAL SYNDROME 22 0.0005
560 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
561 RESPIRATORY FAILURE 38 0.0005
562 AFFECT LABILITY 5 0.0005
563 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
564 COGNITIVE DISORDER 24 0.0005
565 INFLAMMATORY BOWEL DISEASE 5 0.0005
566 ACUTE MYOCARDIAL INFARCTION 15 0.0005
567 BLOOD ALBUMIN DECREASED 4 0.0005
568 HAEMATOMA 13 0.0005
569 ATRIAL FLUTTER 4 0.0005
570 BLOOD DISORDER 4 0.0005
571 UTERINE CANCER 4 0.0005
572 SINUSITIS 51 0.0005
573 LEUKOCYTOSIS 9 0.0005
574 DYSKINESIA 20 0.0005
575 POST PROCEDURAL INFECTION 4 0.0005
576 PULMONARY OEDEMA 22 0.0005
577 DECUBITUS ULCER 4 0.0005
578 ANXIETY 139 0.0005
579 HICCUPS 4 0.0005
580 CHROMATURIA 11 0.0005
581 TEMPERATURE INTOLERANCE 5 0.0005
582 HEPATIC STEATOSIS 9 0.0005
583 ABDOMINAL DISCOMFORT 81 0.0005
584 ILEUS 6 0.0005
585 HYPERBILIRUBINAEMIA 5 0.0005
586 EOSINOPHIL COUNT INCREASED 4 0.0005
587 MUSCULOSKELETAL STIFFNESS 42 0.0005
588 ILL-DEFINED DISORDER 29 0.0005
589 IMMUNODEFICIENCY 7 0.0005
590 LETHARGY 27 0.0005
591 VITAMIN D DECREASED 4 0.0005
592 ACUTE RESPIRATORY FAILURE 9 0.0005
593 LIVER FUNCTION TEST INCREASED 10 0.0005
594 ACCIDENTAL OVERDOSE 17 0.0005
595 EAR PAIN 9 0.0005
596 MULTI-ORGAN FAILURE 8 0.0005
597 MUSCLE STRAIN 4 0.0005
598 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
599 DRUG DISPENSING ERROR 7 0.0005
600 PRODUCT USE ISSUE 86 0.0005
601 FEELING HOT 28 0.0005
602 ASPIRATION 5 0.0005
603 GROIN PAIN 4 0.0005
604 URTICARIA 76 0.0005
605 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
606 LIVER DISORDER 20 0.0005
607 ABASIA 11 0.0004
608 MICTURITION URGENCY 5 0.0004
609 RENAL INJURY 13 0.0004
610 AGITATION 32 0.0004
611 HYPOKALAEMIA 20 0.0004
612 APHONIA 6 0.0004
613 BACTERIAL INFECTION 8 0.0004
614 LUNG DISORDER 21 0.0004
615 GAIT DISTURBANCE 82 0.0004
616 DEFORMITY 4 0.0004
617 BURNING SENSATION 30 0.0004
618 KNEE ARTHROPLASTY 9 0.0004
619 SPLENOMEGALY 5 0.0004
620 SKIN REACTION 6 0.0004
621 CONTUSION 41 0.0004
622 DYSARTHRIA 16 0.0004
623 DRUG ADMINISTRATION ERROR 13 0.0004
624 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
625 SPEECH DISORDER 22 0.0004
626 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
627 BLOOD UREA INCREASED 7 0.0004
628 PARAESTHESIA ORAL 6 0.0004
629 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
630 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
631 PULMONARY EMBOLISM 39 0.0004
632 VITAMIN D DEFICIENCY 4 0.0004
633 UNEVALUABLE EVENT 31 0.0004
634 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
635 PSYCHOTIC DISORDER 12 0.0004
636 PARANOIA 7 0.0004
637 CEREBRAL DISORDER 3 0.0004
638 TENDON RUPTURE 5 0.0004
639 LIMB INJURY 11 0.0004
640 ARTHROPOD BITE 3 0.0004
641 WHEEZING 24 0.0004
642 LIGAMENT SPRAIN 4 0.0004
643 HEPATOTOXICITY 9 0.0004
644 GENERALISED OEDEMA 5 0.0004
645 HAEMATOCRIT DECREASED 8 0.0004
646 OVARIAN CYST 4 0.0004
647 PREGNANCY 8 0.0004
648 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
649 DRY MOUTH 32 0.0004
650 SUBARACHNOID HAEMORRHAGE 4 0.0004
651 INTRAOCULAR PRESSURE INCREASED 5 0.0004
652 EAR DISCOMFORT 4 0.0004
653 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
654 JOINT SWELLING 47 0.0004
655 CONGENITAL ANOMALY 3 0.0004
656 TENDONITIS 6 0.0004
657 ALOPECIA 76 0.0004
658 TOOTHACHE 7 0.0004
659 EJECTION FRACTION DECREASED 6 0.0004
660 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
661 ARTHRALGIA 160 0.0004
662 TENDERNESS 4 0.0004
663 NODULE 5 0.0004
664 WEIGHT FLUCTUATION 4 0.0004
665 AFFECTIVE DISORDER 3 0.0004
666 ARTHRITIS 30 0.0004
667 ANHEDONIA 10 0.0004
668 THERAPEUTIC RESPONSE DECREASED 23 0.0004
669 PULMONARY CONGESTION 5 0.0004
670 BRONCHITIS 28 0.0004
671 HALLUCINATION, AUDITORY 6 0.0004
672 HEPATIC FUNCTION ABNORMAL 14 0.0004
673 HEART RATE INCREASED 37 0.0004
674 SOMNOLENCE 75 0.0004
675 JAUNDICE 10 0.0004
676 MENTAL IMPAIRMENT 9 0.0004
677 DIZZINESS 185 0.0004
678 DECREASED APPETITE 86 0.0004
679 OEDEMA PERIPHERAL 45 0.0004
680 AMNESIA 24 0.0004
681 SLEEP DISORDER 26 0.0004
682 RESPIRATORY DISORDER 11 0.0004
683 BLOOD PRESSURE INCREASED 56 0.0004
684 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
685 SEROTONIN SYNDROME 7 0.0004
686 STEVENS-JOHNSON SYNDROME 8 0.0004
687 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
688 CHEST PAIN 66 0.0004
689 FISTULA 4 0.0004
690 CANDIDA INFECTION 6 0.0004
691 HEMIPARESIS 6 0.0004
692 MYOCARDIAL ISCHAEMIA 4 0.0004
693 CHOLECYSTECTOMY 4 0.0003
694 DYSPNOEA 197 0.0003
695 BLOOD MAGNESIUM DECREASED 3 0.0003
696 TASTE DISORDER 7 0.0003
697 TOXICITY TO VARIOUS AGENTS 58 0.0003
698 CONFUSIONAL STATE 55 0.0003
699 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
700 VOMITING 159 0.0003
701 TREATMENT FAILURE 28 0.0003
702 MUSCLE SPASMS 62 0.0003
703 TREMOR 56 0.0003
704 PULMONARY MASS 5 0.0003
705 MIGRAINE 32 0.0003
706 HYPERLIPIDAEMIA 4 0.0003
707 FEAR 9 0.0003
708 HYPERHIDROSIS 43 0.0003
709 EXPIRED PRODUCT ADMINISTERED 11 0.0003
710 EMOTIONAL DISTRESS 40 0.0003
711 ADRENAL INSUFFICIENCY 4 0.0003
712 NOCTURIA 4 0.0003
713 OSTEOPENIA 5 0.0003
714 PAIN IN EXTREMITY 97 0.0003
715 TREATMENT NONCOMPLIANCE 18 0.0003
716 IMPAIRED WORK ABILITY 7 0.0003
717 SKIN DISCOLOURATION 15 0.0003
718 OFF LABEL USE 282 0.0003
719 TOOTH EXTRACTION 4 0.0003
720 CHRONIC KIDNEY DISEASE 24 0.0003
721 HEADACHE 198 0.0003
722 MUSCLE ATROPHY 4 0.0003
723 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
724 BACK PAIN 73 0.0003
725 LIVER FUNCTION TEST ABNORMAL 9 0.0003
726 DYSTONIA 6 0.0003
727 HIATUS HERNIA 4 0.0003
728 BLOOD POTASSIUM INCREASED 5 0.0003
729 HAEMORRHOIDS 6 0.0003
730 PRURITUS 118 0.0003
731 SEPSIS 34 0.0003
732 METASTASES TO BONE 5 0.0003
733 MUSCLE TWITCHING 7 0.0003
734 DISORIENTATION 12 0.0003
735 BLADDER DISORDER 3 0.0003
736 ADVERSE REACTION 4 0.0003
737 DEVICE ISSUE 27 0.0003
738 EYE HAEMORRHAGE 4 0.0003
739 NASOPHARYNGITIS 55 0.0003
740 QUALITY OF LIFE DECREASED 4 0.0003
741 DISTURBANCE IN ATTENTION 16 0.0003
742 OVERDOSE 64 0.0003
743 FACE OEDEMA 5 0.0003
744 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
745 PYREXIA 102 0.0003
746 DYSPEPSIA 29 0.0003
747 PALLOR 8 0.0003
748 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
749 HALLUCINATION 22 0.0003
750 LIMB DISCOMFORT 9 0.0003
751 VISUAL IMPAIRMENT 36 0.0003
752 SYNCOPE 29 0.0003
753 TOOTH LOSS 6 0.0003
754 FEELING COLD 8 0.0003
755 COORDINATION ABNORMAL 4 0.0003
756 DERMATITIS 6 0.0003
757 EOSINOPHILIA 5 0.0003
758 FLUSHING 29 0.0003
759 BLOOD TEST ABNORMAL 4 0.0003
760 ASTHMA 32 0.0003
761 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
762 OSTEONECROSIS OF JAW 7 0.0003
763 LYMPHOCYTE COUNT DECREASED 5 0.0003
764 DRUG ERUPTION 5 0.0003
765 HEPATOCELLULAR INJURY 4 0.0003
766 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
767 THIRST 5 0.0003
768 FAECES DISCOLOURED 6 0.0003
769 DEVICE DISLOCATION 12 0.0003
770 FLUID RETENTION 14 0.0003
771 PELVIC PAIN 5 0.0003
772 BONE DISORDER 5 0.0003
773 OSTEONECROSIS 9 0.0003
774 VISUAL ACUITY REDUCED 9 0.0003
775 CARDIOMYOPATHY 4 0.0003
776 DYSGEUSIA 20 0.0003
777 DEPRESSION 61 0.0003
778 ATRIAL FIBRILLATION 26 0.0003
779 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
780 BALANCE DISORDER 23 0.0003
781 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
782 DYSPHAGIA 25 0.0003
783 BLOOD BILIRUBIN INCREASED 7 0.0003
784 WEIGHT INCREASED 58 0.0003
785 DRUG INTERACTION 41 0.0003
786 ASTHENIA 97 0.0003
787 ABDOMINAL PAIN 60 0.0003
788 ERYTHEMA 53 0.0003
789 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
790 CHILLS 30 0.0003
791 PERIPHERAL SWELLING 39 0.0003
792 BACTERAEMIA 3 0.0003
793 NEUROPATHY PERIPHERAL 24 0.0003
794 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
795 METABOLIC ACIDOSIS 8 0.0002
796 BLOOD PRESSURE FLUCTUATION 6 0.0002
797 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
798 NERVOUSNESS 13 0.0002
799 ABDOMINAL PAIN UPPER 51 0.0002
800 PAIN IN JAW 7 0.0002
801 PANIC ATTACK 9 0.0002
802 PLEURAL EFFUSION 15 0.0002
803 PANCREATITIS 13 0.0002
804 SWELLING FACE 16 0.0002
805 RED BLOOD CELL COUNT DECREASED 7 0.0002
806 ENCEPHALOPATHY 6 0.0002
807 LUNG NEOPLASM MALIGNANT 10 0.0002
808 EXTRAPYRAMIDAL DISORDER 6 0.0002
809 RENAL FAILURE 32 0.0002
810 COAGULOPATHY 4 0.0002
811 HALLUCINATION, VISUAL 5 0.0002
812 ANGER 8 0.0002
813 HYPOPHAGIA 6 0.0002
814 RETCHING 5 0.0002
815 PRODUCT USE IN UNAPPROVED INDICATION 58 0.0002
816 RECTAL HAEMORRHAGE 10 0.0002
817 NAUSEA 184 0.0002
818 PRURITUS GENERALISED 5 0.0002
819 CORONARY ARTERY DISEASE 7 0.0002
820 SEPTIC SHOCK 10 0.0002
821 ORTHOSTATIC HYPOTENSION 4 0.0002
822 HAEMORRHAGE 24 0.0002
823 RHEUMATOID ARTHRITIS 26 0.0002
824 BEDRIDDEN 3 0.0002
825 NO ADVERSE EVENT 41 0.0002
826 TOOTH DISORDER 5 0.0002
827 SWOLLEN TONGUE 7 0.0002
828 GASTROINTESTINAL DISORDER 20 0.0002
829 DYSPHONIA 13 0.0002
830 INJECTION SITE SWELLING 17 0.0002
831 HYPERGLYCAEMIA 8 0.0002
832 INSOMNIA 58 0.0002
833 PERICARDIAL EFFUSION 5 0.0002
834 CONSTIPATION 47 0.0002
835 DEVICE MALFUNCTION 15 0.0002
836 CHOLELITHIASIS 7 0.0002
837 FALL 71 0.0002
838 VERTIGO 13 0.0002
839 BLOOD SODIUM DECREASED 4 0.0002
840 FRACTURE 4 0.0002
841 BLOOD URINE PRESENT 4 0.0002
842 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
843 DIABETES MELLITUS 16 0.0002
844 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
845 GLAUCOMA 4 0.0002
846 HERNIA 4 0.0002
847 RASH 90 0.0002
848 PALPITATIONS 24 0.0002
849 ANAEMIA 39 0.0002
850 HAEMATURIA 7 0.0002
851 MEMORY IMPAIRMENT 28 0.0002
852 NEOPLASM PROGRESSION 7 0.0002
853 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
854 PNEUMONIA ASPIRATION 5 0.0002
855 IRRITABILITY 12 0.0002
856 CYTOKINE RELEASE SYNDROME 4 0.0002
857 FATIGUE 154 0.0002
858 FEEDING DISORDER 4 0.0002
859 PRODUCT PREPARATION ERROR 4 0.0002
860 PNEUMONIA 63 0.0002
861 RESPIRATORY TRACT INFECTION 5 0.0002
862 UNDERDOSE 14 0.0002
863 DEAFNESS 5 0.0002
864 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
865 DYSURIA 7 0.0002
866 GASTRITIS 5 0.0002
867 PRODUCTIVE COUGH 9 0.0002
868 HYPOTHYROIDISM 6 0.0002
869 CHEST DISCOMFORT 19 0.0002
870 FREQUENT BOWEL MOVEMENTS 5 0.0002
871 THROAT TIGHTNESS 5 0.0002
872 RASH PRURITIC 10 0.0002
873 FEELING ABNORMAL 44 0.0002
874 SKIN LESION 5 0.0002
875 ANGIOEDEMA 8 0.0002
876 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
877 FUNGAL INFECTION 6 0.0002
878 LEUKOPENIA 9 0.0002
879 TRANSAMINASES INCREASED 4 0.0002
880 COLITIS ULCERATIVE 8 0.0002
881 ORAL PAIN 4 0.0002
882 PANCREATITIS ACUTE 4 0.0002
883 HEART RATE IRREGULAR 4 0.0002
884 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
885 EXTRA DOSE ADMINISTERED 7 0.0002
886 HYPERKALAEMIA 6 0.0002
887 CARDIAC DISORDER 16 0.0002
888 SURGERY 10 0.0002
889 ASCITES 5 0.0002
890 LYMPHADENOPATHY 6 0.0002
891 ARRHYTHMIA 8 0.0002
892 POLLAKIURIA 7 0.0002
893 BLOOD POTASSIUM DECREASED 5 0.0002
894 HEPATIC FAILURE 5 0.0002
895 LOCALISED INFECTION 4 0.0002
896 AGGRESSION 8 0.0002
897 BONE DENSITY DECREASED 5 0.0002
898 EYE PAIN 9 0.0002
899 URINARY TRACT INFECTION 27 0.0002
900 CYSTITIS 5 0.0002
901 SKIN ULCER 4 0.0002
902 NASAL CONGESTION 9 0.0002
903 EYE DISORDER 5 0.0002
904 SKIN DISORDER 5 0.0001
905 CARDIAC FAILURE 12 0.0001
906 CARDIAC FAILURE CONGESTIVE 12 0.0001
907 PNEUMONITIS 4 0.0001
908 HOT FLUSH 11 0.0001
909 VISION BLURRED 20 0.0001
910 MALAISE 63 0.0001
911 HAEMOPTYSIS 4 0.0001
912 MYOCARDIAL INFARCTION 25 0.0001
913 WEIGHT DECREASED 40 0.0001
914 RENAL IMPAIRMENT 12 0.0001
915 HYPONATRAEMIA 8 0.0001
916 RENAL FAILURE ACUTE 6 0.0001
917 HYPOACUSIS 6 0.0001
918 PANCREATIC CARCINOMA 4 0.0001
919 DEVICE LEAKAGE 6 0.0001
920 ACUTE KIDNEY INJURY 21 0.0001
921 HOSPITALISATION 21 0.0001
922 BONE PAIN 8 0.0001
923 CEREBROVASCULAR ACCIDENT 23 0.0001
924 COUGH 38 0.0001
925 MYALGIA 23 0.0001
926 THROAT IRRITATION 6 0.0001
927 LACRIMATION INCREASED 4 0.0001
928 EMOTIONAL DISORDER 4 0.0001
929 FEMUR FRACTURE 4 0.0001
930 HAEMOGLOBIN DECREASED 13 0.0001
931 BLOOD GLUCOSE DECREASED 6 0.0001
932 INTENTIONAL OVERDOSE 8 0.0001
933 CEREBRAL INFARCTION 3 0.0001
934 BLOOD CREATININE INCREASED 8 0.0001
935 DEHYDRATION 16 0.0001
936 CARDIOVASCULAR DISORDER 3 0.0001
937 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
938 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
939 INJECTION SITE REACTION 8 0.0001
940 NIGHTMARE 4 0.0001
941 ABDOMINAL DISTENSION 12 0.0001
942 MENTAL DISORDER 5 0.0001
943 DIARRHOEA 73 0.0001
944 THROMBOSIS 9 0.0001
945 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
946 INJECTION SITE PAIN 34 0.0001
947 HAEMATOCHEZIA 6 0.0001
948 RENAL DISORDER 5 0.0001
949 THROMBOCYTOPENIA 12 0.0001
950 DYSPNOEA EXERTIONAL 4 0.0001
951 DRUG DEPENDENCE 17 0.0001
952 COLITIS 4 0.0001
953 DISEASE RECURRENCE 5 0.0001
954 ANGINA PECTORIS 3 0.0001
955 INTERSTITIAL LUNG DISEASE 5 0.0001
956 HYPOGLYCAEMIA 5 0.0001
957 ABNORMAL BEHAVIOUR 4 0.0001
958 DRY EYE 5 0.0001
959 DEVICE BREAKAGE 4 0.0001
960 SKIN BURNING SENSATION 7 0.0001
961 THERAPY CESSATION 5 0.0001
962 OROPHARYNGEAL PAIN 9 0.0001
963 INFLUENZA LIKE ILLNESS 8 0.0001
964 BLOOD GLUCOSE INCREASED 17 0.0001
965 SUICIDAL IDEATION 8 0.0001
966 EYE IRRITATION 5 0.0001
967 CATARACT 5 0.0001
968 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
969 INJECTION SITE ERYTHEMA 10 0.0001
970 PANCYTOPENIA 4 0.0001
971 DEATH 60 0.0001
972 SUICIDE ATTEMPT 4 0.0001
973 INCORRECT DOSE ADMINISTERED 15 0.0001
974 BREAST CANCER 6 0.0001
975 RHINORRHOEA 4 0.0001
976 DRUG ABUSE 5 0.0001
977 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
978 PRODUCT STORAGE ERROR 5 0.0001
979 INTENTIONAL PRODUCT MISUSE 5 0.0001
980 PLATELET COUNT DECREASED 6 0.0001
981 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
982 EPISTAXIS 4 0.0001
983 DRY SKIN 7 0.0001
984 NEUTROPENIA 7 0.0001
985 COVID-19 9 0.0001
986 DRUG DOSE OMISSION 8 0.0000
987 PSORIASIS 6 0.0000
988 ACNE 3 0.0000
989 INFLUENZA 4 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
991 PRODUCT DOSE OMISSION ISSUE 6 0.0000